ErbulozoleAlternative Names: R 55104
Latest Information Update: 25 Aug 1994
$50 / €47 *
At a glance
- Originator Janssen L.P.
- Class Antineoplastics; Dioxolanes; Radioprotectives; Radiosensitisers; Small molecules
- Mechanism of Action Microtubule protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer